Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fanin

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Haematologica|December 1, 2001
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experienceA Sperotto, F Zaja, D Damiani, et al.
Haematologica|September 1, 1992
Advances in prognosis of chronic myeloid leukemiaM Baccarani, D Russo, R Fanin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphomaA Candoni, C Filì, R Trevisan, et al.
Bone Marrow Transplantation|January 1, 1989
The prognosis of chronic myeloid leukemiaM Baccarani, D Russo, E Zuffa, et al.
Bone Marrow Transplantation|January 18, 2005
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusionC Skert, F Patriarca, F Zaja, et al.
European Journal of Haematology|June 26, 2001
Pseudomonas pickettii (Biovar VA-II): a rare cause of bacteremias in haematologic patientsA Candoni, R Trevisan, F Patriarca, et al.
Haematologica|July 11, 1998
Autologous stem cell transplantation in multiple myeloma: a single center experienceF Patriarca, R Fanin, F Silvestri, et al.
Leukemia & Lymphoma|August 26, 1998
Multiple myeloma: presenting features and survival according to hospital referral. Eastern Cooperative Study Group on Monoclonal GammopathiesF Patriarca, R Fanin, F Silvestri, et al.
Endoscopy|October 1, 1994
Esophageal polyp as the sole manifestation of relapse seven years after treatment for Hodgkin's diseaseM Melato, S Bucconi, R Fanin, et al.
Bone Marrow Transplantation|April 22, 2008
What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?A Candoni, E Simeone, M Tiribelli, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Haematologica|December 1, 2001
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experienceA Sperotto, F Zaja, D Damiani, et al.
Haematologica|September 1, 1992
Advances in prognosis of chronic myeloid leukemiaM Baccarani, D Russo, R Fanin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphomaA Candoni, C Filì, R Trevisan, et al.
Bone Marrow Transplantation|January 1, 1989
The prognosis of chronic myeloid leukemiaM Baccarani, D Russo, E Zuffa, et al.
Bone Marrow Transplantation|January 18, 2005
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusionC Skert, F Patriarca, F Zaja, et al.
European Journal of Haematology|June 26, 2001
Pseudomonas pickettii (Biovar VA-II): a rare cause of bacteremias in haematologic patientsA Candoni, R Trevisan, F Patriarca, et al.
Haematologica|July 11, 1998
Autologous stem cell transplantation in multiple myeloma: a single center experienceF Patriarca, R Fanin, F Silvestri, et al.
Leukemia & Lymphoma|August 26, 1998
Multiple myeloma: presenting features and survival according to hospital referral. Eastern Cooperative Study Group on Monoclonal GammopathiesF Patriarca, R Fanin, F Silvestri, et al.
Endoscopy|October 1, 1994
Esophageal polyp as the sole manifestation of relapse seven years after treatment for Hodgkin's diseaseM Melato, S Bucconi, R Fanin, et al.
Bone Marrow Transplantation|April 22, 2008
What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?A Candoni, E Simeone, M Tiribelli, et al.
Pageof 16